96 related articles for article (PubMed ID: 3105044)
1. Induction of cytotoxic capacity by recombinant gamma interferon in human myelomonocytic leukaemia cell lines.
Kuosmanen M; Sarelin H; Andersson LC
Scand J Immunol; 1987 Mar; 25(3):219-23. PubMed ID: 3105044
[TBL] [Abstract][Full Text] [Related]
2. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
3. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
[TBL] [Abstract][Full Text] [Related]
4. Interferon gamma-treated human macrophages display enhanced cytolysis and generation of reactive oxygen metabolites but reduced ingestion upon Fc receptor triggering.
Jungi TW; Rüegg SJ; Morell A
Hum Immunol; 1989 Feb; 24(2):77-93. PubMed ID: 2494137
[TBL] [Abstract][Full Text] [Related]
5. Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937.
Harris PE; Ralph P; Litcofsky P; Moore MA
Cancer Res; 1985 Jan; 45(1):9-13. PubMed ID: 2981161
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
[TBL] [Abstract][Full Text] [Related]
7. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
Trinchieri G; O'Brien T; Shade M; Perussia B
J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
[TBL] [Abstract][Full Text] [Related]
8. Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines.
Hattori T; Pack M; Bougnoux P; Chang ZL; Hoffman T
J Clin Invest; 1983 Jul; 72(1):237-44. PubMed ID: 6348086
[TBL] [Abstract][Full Text] [Related]
9. Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis.
Vaickus L; Biddle W; Cemerlić D; Foon KA
Blood; 1990 Jun; 75(12):2408-16. PubMed ID: 2140949
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.
Caron PC; Lai LT; Scheinberg DA
Clin Cancer Res; 1995 Jan; 1(1):63-70. PubMed ID: 9815888
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha A/D blocks an increase in Fc receptors of a human promyelocytic leukemia cell line (HL-60) induced by other recombinant interferons.
Hemmi H; Nakamura T; Aso H; Ishida N
J Interferon Res; 1987 Aug; 7(4):397-407. PubMed ID: 2959729
[TBL] [Abstract][Full Text] [Related]
12. Procoagulant induction by human lymphokine and interferon gamma/PMA on a myelomonocytic cell line, RC2a.
Geczy CL; Jones A
Br J Haematol; 1988 Oct; 70(2):211-8. PubMed ID: 3142514
[TBL] [Abstract][Full Text] [Related]
13. Interferon and butyrate treatment leads to a decreased sensitivity of NK target cells to lysis by homologous but not by heterologous effector cells.
Laskay T; Kiessling R
Nat Immun Cell Growth Regul; 1986; 5(4):211-20. PubMed ID: 3095635
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
Sung MW; Johnson JT; Van Dongen G; Whiteside TL
Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
[TBL] [Abstract][Full Text] [Related]
15. IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.
Dawson MJ; Trapani JA
J Cell Biochem; 1995 Jan; 57(1):39-51. PubMed ID: 7536752
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor and interferon-gamma augment anticolon antibody- dependent cellular cytotoxicity in ulcerative colitis.
Watanabe N; Maeda M; Okamoto T; Sasaki H; Tsuji N; Akiyama S; Kobayashi D; Sato T; Yamauchi N; Niitsu Y
Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):15-26. PubMed ID: 8683036
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine inducing "terminal differentiation" of the human monoblast leukemia line U937: a role for gamma interferon.
Ralph P; Harris PE; Punjabi CJ; Welte K; Litcofsky PB; Ho MK; Rubin BY; Moore MA; Springer TA
Blood; 1983 Dec; 62(6):1169-75. PubMed ID: 6416332
[TBL] [Abstract][Full Text] [Related]
18. Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates.
Nair MP; Schwartz SA; Menon M
Cell Immunol; 1985 Aug; 94(1):159-71. PubMed ID: 3926326
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
Rüegg SJ; Jungi TW
Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
